169329 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION
#302Beef-specific age determination marker containing the p21 protein
#303MATERIALS AND METHODS FOR DIAGNOSIS OF PERI-IMPLANT BONE AND JOINT INFECTIONS USING PROPHENOLOXIDASE PATHWAY
#304Fibronectin binding domains with reduced immunogenicity
#305Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies
#306Biomarkers of osteoarthritis
#307TROPONIN AND BNP BASED DIAGNOSIS OF RISK PATIENTS AND CAUSE OF STROKE
#308METHODS AND SYSTEM FOR DETERMINING THE DISEASE STATUS OF A SUBJECT
#309BAG3 as a target for therapy of heart failure
#310IGFBP7 for diagnosing diastolic dysfunction
#311Peptides and compositions for treatment of joint damage
#312Method for obtaining thin fibril collagen by contacting native collagen with an antibody
#313Method of Detection of Summed Cardiac Troponins for Cardiovascular Risk Stratification
#314Modulation of Exon Recognition in Pre-mRNA By Interfering with the Secondary RNA Structure
#315Methods and monitoring of treatment with a WNT pathway inhibitor
#316Magnetic apparatus and methods of use
#317Uses of GLI1 in detecting tissue fibrosis
#318Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides
#319Methods for diagnosing or monitoring muscular dystrophies
#320Therapeutic target for musculoskeletal inflammation
#321Ras pathways as markers of protection against HIV and methods to improve vaccine efficacy
#322METHOD FOR IDENTIFYING AND SELECTING CARDIOMYOCYTES
#323Methods and compositions for expressing functional class XIV myosin
#324METHODS FOR THE DETECTION AND QUANTIFICATION OF CIRCULATING ENDOTHELIAL CELLS
#325Biomarker for cardiac disorders
#326System and method for studying matrix vesicle calcification
#327Methods for detecting cardiac damage
#328Methods to detect myocardial injury and uses thereof
#329Peptides and compositions for treatment of joint damage
#330Ultra-small apoB-containing particles and methods of use thereof
#331Methods for treating or reducing the risk of arthritis in a subject by administering gelsolin
#332Prevention of tissue ischemia and related methods
#333Compositions comprising the NC2 domain of collagen IX and methods of using same
#334Methods and means for treatment of osteoarthritis
#335Using nucleic acids encoding NAP-2 and TGF-alpha polypeptides to improve cardiac function
#336Highly sensitive system and method for analysis of troponin
#337Devices and methods related to airway inflammation
#338Predicting coronary artery disease and risk of cardiovascular events
#339Methods and apparatus for assessment of risk for joint injury
#340Muscle specific tyrosine kinase-fluorophore conjugate compositions, kits and methods of using
#341METHODS FOR PREDICTING RHEUMATOID ARTHRITIS TREATMENT RESPONSE
#342Multiple hybrid immunoassay
#343Method for measuring the plasma concentration of an analyte directly on a whole blood sample
#344METHODS FOR ANALYZING ELASTIC FIBER INJURY MARKERS AND DIAGNOSIS OF DISEASES ASSOCIATED WITH ELASTIC FIBER INJURY
#345Inflammatory disease treatment composition including anti-myosin regulatory light-chain polypeptide antibody
#346CHONDROADHERIN FRAGMENTS AS INDICATORS OF INTERVERTEBRAL DISC DEGENERATION
#347CARDIOVASCULAR RISK EVENT PREDICTION AND USES THEREOF
#348Composition comprising farnesol and use thereof
#349Collagen Type VI Alpha-1 Assay
#350MARKER FOR DIAGNOSING AGE-RELATED MACULAR DEGENERATION, AND METHOD FOR DIAGNOSING AGE-RELATED MACULAR DEGENERATION BY USING SAME
#351METHODS FOR TREATMENT OF CARDIOMYOPATHY
#352Method and device for immunoassay using nucleotide conjugates
#353Collagen IV binding assay for the detection of collagen VII
#354Gene Expression Control DNA Element and Associated Protein
#355CTHRC1 RECEPTOR AND METHODS OF USE THEREOF
#356METHOD T0 MAKE AN AQUEOUS POUR POINT DEPRESSANT DISPERSION COMPOSITION
#357Methods and products for in vitro diagnosis, in vitro prognosis and the development of drugs against invasive carcinomas
#358Cell culture models for validating candidate compounds for use in treating COPD and other diseases
#359SYSTEMS, METHODS AND COMPUTER READABLE STORAGE MEDIA FOR ANALYZING A SAMPLE
#360Protective effect of DMPC, DMPG, DMPC/DMPG, EGPG, LysoPG and LysoPC against drugs that cause channelopathies
#361Humanized or affinity-matured anti Ang-2 antibody and uses thereof
#362Method for treating heart disease by inhibiting the Coxsackievirus-Adenovirus Receptor
#363Determining pathological cartilage turnover
#364METHODS FOR TREATMENT WITH BUCINDOLOL BASED ON GENETIC TARGETING
#365Generation of airway and lung progenitors and epithelial cells and three-dimensional anterior foregut spheres
#366Method for diagnosing muscular dystrophy
#367Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
#368TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION
#369NTproBNP AND cTnT BASED THERAPY GUIDANCE IN HEART FAILURE
#370Methods for detecting the presence of irritable bowel syndrome and system for diagnosing same
#371Immunoassay kit for quantification of BNP and proBNP
#372TREATING DISEASES BY MODULATING A SPECIFIC ISOFORM OF MKL1
#373TROPONIN I (TnI) AS A SUITABLE MARKER PROTEIN FOR THE DETERMINATION OF ANIMAL SPECIES ORIGIN OF ADIPOSE TISSUE
#374IDENTIFICATION OF PATIENTS WITH ABNORMAL FRACTIONAL SHORTENING
#375Methods for treatment of cardiovascular disease
#376Long rigid spacers to enhance binding kinetics in immunoassays
#377METHOD AND AGENTS TO QUANTIFY PROTEINS FROM TISSUES
#378METHODS AND COMPOSITIONS RELATED TO THE SMCHD1 GENE
#379BAG3 as biochemical serum and tissue marker
#380Ultra-small ApoB-containing particles and methods of use thereof
#381Detection of diagnostic peptides
#3823D in vitro bi-phasic cartilage-bone construct
#383Compositions and methods related to protein displacement therapy for myotonic distrophy
#384Compounds and compositions for the treatment of muscular disorders
#385Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure
#386ASSAY LABEL
#387Fibronectin binding domains with reduced immunogenicity
#388Methods for detecting oncofetal fibronectin
#389Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof
#390METHOD FOR IDENTIFYING A SUBJECT AT RISK OF DEVELOPING HEART FAILURE BY DETERMINING THE LEVEL OF GALECTIN-3 OR THROMBOSPONDIN-2
#391Catalyst and process for preparing acrolein and/or acrylic acid by dehydration reaction of glycerin
#392Methods for detecting cardiac damage
#393METHOD OF PREPARING AN ARTIFICIAL TOOTH PRIMORDIUM IN VITRO AND ARTIFICIALTOOTH PRIMORDIUM DERIVED THEREFROM
#394MULTILEVEL ANALYTE ASSAY
#395Method of determining the viability of at least one cell
#396HYDROGEL-MEDIATED TISSUE ANALYSIS
#397Synthetic mammalian neuromuscular junction and method of screening for a candidate drug thereon
#398FORENSIC METHOD
#399Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#400Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#401In vitro assessment of cardiovascular events by assay for neo-eptitopes of titin protein
#402Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure
#403METHODS OF USING F-SPONDIN AS A BIOMARKER FOR CARTILAGE DEGENERATIVE CONDITIONS AND BONE DISEASES
#404CARDIAC STEM CELL AND MYOCYTE SECRETED PARACRINE FACTORS AND USES THEREOF
#405Method for treating osteoporosis
#406Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure
#407Biglycan variant polypeptides and methods of use
#408Molecular flux rates through critical pathways measured by stable isotope labeling In Vivo, as biomarkers of drug action and disease activity
#409Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#410IMMUNOASSAY TEST STRIP FOR USE IN A DIAGNOSTIC SYSTEM
#411Mid-regional pro-atrial natriuretic peptide (pro-ANP) for the identification of patients with atrial fibrillation with an onset of less than 48 hours ago
#412Method of using papain to extract collagen from aquatic animals
#413Multiple hybrid immunoassay
#414Methods and compositions for the diagnosis of ovarian cancer
#415Novel Biomarkers For Cardiovascular Injury
#416Diagnosis and treatments relating to TH2 inhibition
#417Diagnosis and treatments relating to TH2 inhibition
#418BIOMARKERS FOR OSTEOARTHRITIS
#419MYOSIN BINDING PROTEIN-C FOR USE IN METHODS RELATING TO DIASTOLIC HEART FAILURE
#420Method of Predicting Increased Risk of Suffering Statin-induced Adverse Drug Reactions
#421Spectroscopic Troponin I Detection and Quantification Using Plasmonic Nano-Materials
#422Methods, compositions and kits for modulating trans-differentiation of muscle satellite cells
#423Combination for early exclusion of acute myocardial infarction
#424Probe for analyzing biological tissue and method for utilizing same
#425Predicting Atrial Fibrillation Recurrence by Protease and Protease Inhibitor Profiling
#426Method for measuring cardiac troponin
#427Nitrated cardiac troponin I as a biomarker of cardiac ischemia
#428Methods, kits and systems for signal amplification for bioassays using zinc nanoparticles
#429Assay for colon and other cancers in humans
#430BIN1 expression as a marker of skeletal muscle mass and neurological conditions
#431BIOMARKERS AND THERAPEUTIC TARGETS FOR TREATING CARDIOMYOPATHIES AND CONGESTIVE HEART FAILURE
#432Serum MG53 as a diagnostic marker for tissue injury
#433Methods for treatment of cardiovascular disease
#434BNP-SP antibodies
#435METHODS FOR PREDICTING AND TREATING MYOCARDIAL DAMAGE
#436Hybridoma cell line for producing antibody for type II collagen
#437Method for evaluating regenerated cartilage
#438Methods for alleviating facioscapulohumeral dystrophy (FSHD) by N siRNA molecule inhibiting the expression of DUX4-FL
#439Highly sensitive system and method for analysis of troponin
#440Gene expression control DNA element and associated protein
#441Use of VEGF-C agonists for inhibiting ultraviolet B-induced skin damage
#442Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
#443ADHESION SIGNATURES
#444Body fluid BIN1 as a marker of cardiac health
#445In vitro method for diagnosing or predicting hypertension and/or early-stage cardiovascular end-organ damage by determining the concentration of soluble prorenin receptor
#446Method of Detecting Mechanosensing Responses in Bone Cells
#447ASSAY FOR A TYPE II COLLAGEN BIOMARKER
#448Methods and Compositions for Highly Sensitive Detection of Molecules
#449Diagnostic test for cardiomyopathy
#450Highly sensitive system and method for analysis of troponin
#451METHOD FOR TESTING FOR CEREBRAL INFARCTION VIA CARTILAGE ACIDIC PROTEIN 1
#452Fibronectin binding domains with reduced immunogenicity
#453ENGINEERED PROTEIN: "2-COLOR SERCA", AN ION-MOTIVE ATPase FUSED TO CERULEAN AND YELLOW FLUORESCENT PROTEIN
#454Method and device for immunoassay using nucleotide conjugates
#455Myomegalin variant 8
#456Conditional Mst overexpressing construct and conditional myostatin overexpressing transgenic mouse
#457Methods of determining chondrocytes
#458Fibronectin binding domains with reduced immunogenicity
#459NORMALIZATION OF PLATELET BIOMARKERS
#460Methods for detecting oncofetal fibronectin
#461DIAGNOSIS AND MONITORING OF INFLAMMATION, ISCHEMIA AND APPENDICITIS
#462Collagen mimetic peptides for targeting collagen strands for in vitro and in vivo imaging and therapeutic use
#463Recombinant protein capable of binding specifically and quickly to troponin I derived from human myocardium
#464Specific binding sites in collagen for integrins and use thereof
#465Recombinant protein capable of binding specifically and quickly to troponin I derived from human myocardium
#466Devices and methods for controlling actin filaments growth and organization using micropatterned nucleation sites
#467Methods and devices for diagnosing cardiac disorders
#468Control of Cardiac Growth, Differentiation and Hypertrophy
#469Methods of diagnosing and treating heart failure
#470Fibronectin aggrecan biomarker for the identification of spinal and joint source of pain
#471Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure
#472Secreted protein acidic and rich in cysteine (SPARC) protein SRM assay
#473Immunoassay for quantification of an unstable antigen selected from BNP and proBNP
#474PROGNOSTIC TESTS FOR DEVELOPMENT OF DERMAL STRETCH MARKS AND IMPLICATIONS FOR THE PREVENTATIVE TREATMENT THEREOF
#475CATALYST AND PROCESS FOR PREPARING ACROLEIN AND/OR ACRYLIC ACID BY DEHYDRATION REACTION OF GLYCERIN
#476TROPONIN BASED RULE-IN AND RULE-OUT ALGORITHM OF MYOCARDIAL INFARCTION
#477Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney Injury
#478BEEF-SPECIFIC AGE DETERMINATION MARKER CONTAINING THE P21 PROTEIN
#479METHODS OF EVALUATING CELLS AND CELL CULTURES
#480DNA aptamer specifically binding to human cardiac troponin I
#481Method for inhibiting bone resorption
#482Lateral Flow Immunoassay for Detecting Cardiac Troponin I and Myoglobin
#483NOVEL DESMIN PHOSPHORYLATION SITES USEFUL IN DIAGNOSIS AND INTERVENTION OF CARDIAC DISEASE
#484Use of modified extracellular matrix proteins in diagnosis and treatment of atherosclerosis
#485METHODS AND COMPOUNDS FOR MUSCLE GROWTH
#486Prevention of tissue ischemia and related compositions
#487Prevention of tissue ischemia and related methods
#488Methods for treatment with bucindolol based on genetic targeting
#489Thrombospondin Fragments and Uses Thereof In Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents
#490Thrombospondin Fragments and Uses Thereof In Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents
#491Procollagen C-proteinase enhancer (PCPE) biomarker for bone formation
#492Indian Hedgehog (Ihh) as a Marker to Predict Osteoarthritis (OA) and Methods for the Prevention and Treatment of OA
#493Biglycan and related therapeutics and methods of use
#494COLLAGEN NEOEPITOPE ANTIBODY
#495METHOD, KIT OR DIAGNOSTIC FOR THE DETECTION OF REAGENTS WHICH INDUCE ALTERED CONTRACTILITY
#496Blood Biomarkers for Bone Fracture and Cartilage Injury
#497USE OF GALECTIN-3 FOR DETECTING AND PROGNOSING HEART FAILURE AFTER ACUTE CORONARY SYNDROME
#498METHOD FOR IDENTIFYING A SUBJECT AT RISK OF DEVELOPING HEART FAILURE BY DETERMINING THE LEVEL OF GALECTIN-3 OR THROMBOSPONDIN-2
#499Method for Detecting Cardiac Ischemia via Changes in B-Natriuretic Peptide Levels
#500Sequences, antibodies, methods and kits for detection and in vitro assay of periostin, in order to provide a diagnosis, follow-up or prognosis of diseases and biological phenomena involving periostin
#501SPECIFIC BINDING SITES IN COLLAGEN FOR INTEGRINS AND USE THEREOF
#502Use of gelsolin to diagnose and treat inflammatory diseases
#503Method and means for treatment of osteoarthritis
#504METHOED FOR DETECTING CIRCULATING CARTILAGE OLIGOMERIC MATRIX PROTEIN IN THE DIAGNOSIS AND MONITORING OF CIRRHOSIS
#505METHOD OF DETECTING SKELETAL MUSCLE DAMAGE
#506Profiling fragments of elastic fibers and microfibrils as biomarkers for disease
#507Methods and compositions involving nucleotide repeat disorders
#508CMYBP-C and MLC2 as diagnostic markers of cardiac injury
#509Methods and compositions for wound treatment
#510DIAGNOSIS AND TREATMENTS RELATING TO TH2 INHIBITION
#511METHODS OF EVALUATING CELLS AND CELL CULTURES
#512Methods and compositions of nucleic acid ligands for detection of clinical analytes related to human health
#513Type IV collagen-like immunoreactive peptide
#514NOVEL METHODS FOR THE ASSAY OF TROPONIN I AND T AND COMPLEXES OF TROPONIN I AND T AND SELECTION OF ANTIBODIES FOR USE IN IMMUNOASSAYS
#515Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
#516Sclerostin and the inhibition of WNT signaling and bone formation
#517Serum MG53 as a diagnostic marker for tissue injury
#518METHODS FOR DIAGNOSIS AND PROGNOSIS OF CANCER
#519Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#520COLLAGEN EXTRACTION FROM AQUATIC ANIMALS
#521METHOD OF DETERMINING RISK OF ARRHYTHMIA
#522Post-translation modified cardiac troponin T as a biomarker of a risk for heart failure
#523Immunoassay test strip for use in a diagnostic system
#524DETECTION AND/OR TREATMENT OF DISEASES ASSOCIATED WITH AUTOANTIBODIES
#525METHOD OF DETERMINING A PREDISPOSITION TO ATRIAL FIBRILLATION (AF) IN A SUBJECT
#526Method of determining tropomyosin in chitosan
#527Methods for detecting oncofetal fibronectin
#528YKL-40 AS A MARKER FOR SELECTION OF TREATMENT AND MONITORING OF A DISEASE
#529METHODS OF CLASSIFYING THE SEVERITY OF DISEASES OR DISORDERS
#530Methods and means for treatment of osteoarthritis
#531DIAGNOSTIC METHODS USING BNP
#532Use of the SPARC microenvironment signature in the treatment of cancer
#533Detection of specific nitrated markers
#534ENDOSTATIN AS A MARKER OF HEART FAILURE
#535PREDICTING CORONARY ARTERY DISEASE AND RISK OF CARDIOVASCULAR EVENTS
#536Modulation of exon recognition in pre-mRNA by interfering RNA structure
#537GDF15 as a differential marker for spondyloarthropathy
#538GDF15 AS MOLECULAR TOOL TO MONITOR AND ENHANCE PHENOTYPIC STABILITY OF ARTICULAR CHONDROCYTES
#539Generation, expression and characterization of the humanized K33N monoclonal antibody
#540POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN THE PROCESS OF BONE REMODELING
#541Assay for Detecting Cathepsin K Activty in Bone, Cartilage and/or Soft Tissue
#542Methods for treatment of cardiovascular disease
#543SENSORY RECEPTORS FOR CHRONIC FATIGUE AND PAIN AND USES THEREOF
#544Assay for Troponin I using magnetic labels
#545Cardiac stem cell and myocyte secreted paracrine factors
#546Formation of neuromuscular junctions in a co-culture comprising rat muscle cells overlayered with differentiated human spinal cord stem cells in a serum free medium
#547ActRIIB FUSION POLYPEPTIDES AND USES THEREFOR
#548ASSESSMENT OF PROTEIN DEGRADATION BY MEASUREMENT OF COLLAGEN FRAGMENTS
#549DETECTION OF SPECIFIC NITRATED MARKERS
#550BIOMARKERS OF OSTEOARTHRITIS
#551Monitoring myocardial infarction and its treatment
#552NELL-1 enhanced bone mineralization
#553Methods of differentiating and protecting cells by modulating the p38/MEF2 pathway
#554Chitosan having tropomyosin content assessed by method of determining tropomyosin in chitosan
#555METHODS FOR DETECTION AND DIAGNOSIS OF A BONE OR CARTILAGE DISORDER
#556Biglycan and related therapeutics and methods of use
#557COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER
#558Method to identify patients at risk for lung transplant rejection
#559Inducer of chondrocyte proliferation and differentiation
#560BIOMARKER FOR OSTEOARTHRITIS AND/OR OTHER AGEING-RELATED DISEASES, AND USE THEREOF
#561Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof
#562Method of detecting articular cartilage degeneration or damage
#563Diagnosis of collagen IX destruction
#564Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays
#565Assays for human NT-pro B-type natriuretic peptide, human pro B-type natriuretic peptide and human B-type natriuretic peptide
#566METHODS FOR IDENTIFICATION, AND COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES
#567USING CARDIAC TROPONIN FOR MONITORING ANTI-ANGIOGENESIS THERAPY
#568Identification of subjects being susceptible to anti-angiogenesis therapy
#569Highly sensitive system and method for analysis of troponin
#570MULTIMARKER PANEL FOR MONITORING PATIENTS WITH AND WITHOUT OVERT HEART FAILURE
#571DIAGNOSIS OF EARLY STAGE CARDIAC DYSFUNCTION
#572Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
#573Sclerostin and the inhibition of WNT signaling and bone formation
#574Methods for detecting cardiac damage
#575ASSESSMENT OF COMPLICATIONS OF PATIENTS WITH TYPE 1 DIABETES
#576SCREENING METHODS FOR BONE MORPHOGENETIC MIMETICS
#577LATERAL-FLOW IMMUNO-CHROMATOGRAPHIC ASSAY DEVICES
#578CARDIOVASCULAR SAFETY ASSAY
#579BMP-1 PROCOLLAGEN C-PROTEINASE FOR DIAGNOSIS AND TREATMENT OF BONE AND SOFT TISSUE DEFECTS AND DISORDERS
#580H-FABP AS A MARKER FOR MYOCARDIAL HIBERNATION
#581Methods for Diagnosing and Treating Iron Dysregulation
#582Use of B-Type Natriuretic Peptide as a Prognostic Indicator in Acute Coronary Syndromes
#583Thrombospondin Fragments and Uses Thereof in Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents
#584Biomarkers for prediction of major adverse cardiac events and uses thereof
#585Methods and compositions involving nucleotide repeat disorders
#586Method for isolating smooth muscle stem cells
#587Methods and kits for separation and detection of proteins in biological samples
#588Method to identify patients at risk for lung transplant rejection
#589Methods for improving the recovery of troponin I and T in membranes, filters and vessels
#590Diagnostic assay for human matrix GLA-protein and its use as a biomarker
#591Use of FZC18-Containing Collagen 18 Polypeptides for the Treatment, Diagnosis and Outcome Prediction of Diseases
#592Highly sensitive system and methods for analysis of troponin
#593Myoglobin as early predictor of myocardial infarction
#594Use of SLIM-1 in the assessment of heart failure
#595ESTROGEN RECEPTOR-RELATED RECEPTOR GAMMA (ERR GAMMA) IN BONE AND CARTILAGE FORMATION AND METHODS AND COMPOSITIONS RELATING TO SAME
#596USE OF MODIFIED EXTRACELLULAR MATRIX PROTEINS IN DIAGNOSIS AND TREATMENT OF ATHEROSCLEROSIS
#597PROGNOSTIC TESTS FOR DEVELOPMENT OF DERMAL STRETCH MARKS AND IMPLICATIONS FOR THE PREVENTATIVE TREATMENT THEREOF
#598Osteopontin as Novel Prognostic Biomarker for Heart Failure
#599NT-proBNP/troponin ratio for assessing myocardial dysfunction
#600Highly sensitive system and methods for analysis of troponin